Provided by Tiger Trade Technology Pte. Ltd.

Acumen Pharmaceuticals, Inc.

2.70
+0.06502.47%
Volume:166.52K
Turnover:427.18K
Market Cap:163.25M
PE:-1.22
High:2.75
Open:2.56
Low:2.36
Close:2.63
52wk High:3.60
52wk Low:0.8551
Shares:60.57M
Float Shares:32.93M
Volume Ratio:3.60
T/O Rate:0.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2064
EPS(LYR):-1.7051
ROE:-85.93%
ROA:-42.23%
PB:1.75
PE(LYR):-1.58

Loading ...

Acumen Pharmaceuticals Presents Studies on Enhanced Brain Delivery™, Biomarker Research, and Novel Antibodies at Advances in Alzheimer's Treatment at International Conference on Alzheimer’s and Parkinson’s Diseases 2026

GlobeNewswire
·
Mar 17

Maintaining Buy on Acumen (ABOS): EBD-Enabled Alzheimer’s Pipeline, Extended Runway, and Discounted Valuation Ahead of ALTITUDE-AD Readout

TIPRANKS
·
Mar 17

Acumen Pharmaceuticals Is Maintained at Buy by BTIG

Dow Jones
·
Mar 17

Acumen price target raised to $8 from $7 at BTIG

TIPRANKS
·
Mar 17

BUZZ-U.S. STOCKS ON THE MOVE-Customers Bancorp, Forgent Power Solutions, Nvidia

Reuters
·
Mar 17

BUZZ-U.S. STOCKS ON THE MOVE-Dollar Tree, Micron, Customers Bancorp

Reuters
·
Mar 16

Acumen Raises Capital to Advance Enhanced Brain Delivery

TIPRANKS
·
Mar 16

Acumen Pharmaceuticals Shares Up on Positive Alzheimer's Drug Data, $35.8M Private Placement

Dow Jones
·
Mar 16

Acumen Pharmaceuticals publishes corporate presentation on sabirnetug (ACU193) Phase 2 program for early Alzheimer’s disease

Reuters
·
Mar 16

Acumen Pharmaceuticals announces USD 35.75 million private placement at USD 3.3 per share

Reuters
·
Mar 16

Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio

GlobeNewswire
·
Mar 16

Acumen Pharmaceuticals to join Stifel 2026 Virtual CNS Forum fireside chat

Reuters
·
Mar 11

Acumen Pharmaceuticals Chief Legal Officer Derek Meisner Disposes of Common Shares

Reuters
·
Mar 04

Acumen Pharmaceuticals to Present Alzheimer’s Treatment Advances at AD/PD 2026 Conference

Reuters
·
Mar 03

Acumen Pharmaceuticals to Showcase Advances in Alzheimer's Treatment at International Conference on Alzheimer’s and Parkinson’s Diseases 2026

THOMSON REUTERS
·
Mar 03

Analysts Are Bullish on These Healthcare Stocks: vTv Therapeutics (VTVT), Acumen Pharmaceuticals (ABOS)

TIPRANKS
·
Feb 03

Acumen Pharmaceuticals Chief Legal Officer Derek Meisner Reports Disposal of Common Shares

Reuters
·
Jan 29

Analysts Offer Insights on Healthcare Companies: Acumen Pharmaceuticals (ABOS) and InMode (INMD)

TIPRANKS
·
Jan 27

Acumen Pharmaceuticals Is Maintained at Buy by BTIG

Dow Jones
·
Jan 27

U.S. RESEARCH ROUNDUP-AMETEK, Stryker, Zimmer Biomet Holdings

Reuters
·
Jan 27